A Bioinformatic Investigation into the Role of ITGB1 in Cancer Prognosis and Therapeutic Resistance
Mo, X.
Show abstract
Integrin {beta}1 is a crucial transmembrane protein that regulates cellular adhesion, migration, and signal transduction, processes essential for cancer progression. This study investigates the role of ITGB1, the gene that encodes Integrin {beta}1, in various cancers using bioinformatics tools. By analyzing gene expression data across different cancer types and normal tissues, the study identifies significant upregulation of ITGB1 in several cancers. We find elevated expression of ITGB1 is associated with poor prognosis in multiple tumors, suggesting its potential as a biomarker for cancer progression and therapeutic resistance. Further analysis reveals ITGB1s correlation with chemoresistance and immunoresistance genes, highlighting its involvement in cancer treatment evasion. The study also explores the expression and role of genes that are highly related to ITGB1 in tumor and patient prognosis, offering insights into potential molecular pathways and therapeutic targets. These findings underscore the clinical relevance of ITGB1 in cancer prognosis and therapy.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identification of cuproptosis and ferroptosis-related subtypes and development of a prognostic signature in colon cancer 96%
- Glyoxalase 1: emerging biomarker and therapeutic target in cervical cancer progression 96%
- Machine learning based prediction of recurrence after curative resection for rectal cancer 95%
Similar papers in this journal
- Immune Classification of Clear Cell Renal Cell Carcinoma 96%
- Single-cell analysis reveals diversity of tumor-associated macrophages and their interactions with T lymphocytes in glioblastoma 95%
- Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning 95%
Similar papers in this journal
- Patient stratification of clear cell renal cell carcinoma using the global transcription factor activity landscape derived from RNA-seq data 96%
- Systems biomedicine of primary and metastatic colorectal cancer reveals potential therapeutic targets 96%
- BNIP3 upregulation characterizes cancer cell subpopulation with increased fitness and proliferation 95%
Similar papers in this journal
- Enhancing Chemotherapy Response Prediction via Matched Colorectal Tumor-Organoid Gene Expression Analysis and Network-Based Biomarker Selection 96%
- ORMDL1 is upregulated and associated with favorable outcome in colorectal cancer 95%
- Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum 95%
Similar papers in this journal
- Loss of CHGA protein as a potential biomarker for colon cancer diagnosis: a study on biomarker discovery by machine learning and confirmation by immunohistochemistry in colorectal cancer tissue microarrays 96%
- A novel molecular analysis approach in colorectal cancer suggests new treatment opportunities 96%
- COL7A1 expression improves prognosis prediction for patients with clear cell renal cell carcinoma atop of stage 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.